Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Cagnati

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Redox Report : Communications in Free Radical Research|May 17, 2013
Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitorsGiuseppe Murdaca, Francesca Spanò, Paola Cagnati, et al.
International Journal of Cardiology|February 6, 2007
Remission of brucella endocarditis in a patient with mitral valve mechanical prosthesis by antibiotic therapy alone: a case reportGiuseppe Murdaca, Barbara Maria Colombo, Matteo Caiti, et al.
American Journal of Clinical Dermatology|June 3, 2010
Anti-tumor necrosis factor-α treatment with infliximab for disseminated granuloma annulareGiuseppe Murdaca, Barbara Maria Colombo, Gianfranco Barabino, et al.
Expert Opinion on Drug Safety|October 21, 2011
Update upon efficacy and safety of TNF-α inhibitorsGiuseppe Murdaca, Barbara Maria Colombo, Paola Cagnati, et al.
Atherosclerosis|June 8, 2012
Endothelial dysfunction in rheumatic autoimmune diseasesGiuseppe Murdaca, Barbara Maria Colombo, Paola Cagnati, et al.
Human Immunology|June 14, 2011
Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatmentGiuseppe Murdaca, Paola Contini, Maurizio Setti, et al.
The Journal of Rheumatology|November 13, 2008
Recurrent intestinal perforation associated with thrombosis of inferior vena cava: uncommon presentation of antiphospholipid syndromeGiuseppe Murdaca, Paola Cagnati, Rossella Gulli, et al.
The American Journal of Medicine|January 25, 2012
Current views on diagnostic approach and treatment of lymphedemaGiuseppe Murdaca, Paola Cagnati, Rossella Gulli, et al.
Clinical Immunology (Orlando, Fla.)|September 19, 2009
Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitutionGiuseppe Murdaca, Paola Contini, Maurizio Setti, et al.
Clinical and Experimental Medicine|November 15, 2015
Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapyGiuseppe Murdaca, Paola Contini, Paola Cagnati, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Redox Report : Communications in Free Radical Research|May 17, 2013
Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitorsGiuseppe Murdaca, Francesca Spanò, Paola Cagnati, et al.
International Journal of Cardiology|February 6, 2007
Remission of brucella endocarditis in a patient with mitral valve mechanical prosthesis by antibiotic therapy alone: a case reportGiuseppe Murdaca, Barbara Maria Colombo, Matteo Caiti, et al.
American Journal of Clinical Dermatology|June 3, 2010
Anti-tumor necrosis factor-α treatment with infliximab for disseminated granuloma annulareGiuseppe Murdaca, Barbara Maria Colombo, Gianfranco Barabino, et al.
Expert Opinion on Drug Safety|October 21, 2011
Update upon efficacy and safety of TNF-α inhibitorsGiuseppe Murdaca, Barbara Maria Colombo, Paola Cagnati, et al.
Atherosclerosis|June 8, 2012
Endothelial dysfunction in rheumatic autoimmune diseasesGiuseppe Murdaca, Barbara Maria Colombo, Paola Cagnati, et al.
Human Immunology|June 14, 2011
Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatmentGiuseppe Murdaca, Paola Contini, Maurizio Setti, et al.
The Journal of Rheumatology|November 13, 2008
Recurrent intestinal perforation associated with thrombosis of inferior vena cava: uncommon presentation of antiphospholipid syndromeGiuseppe Murdaca, Paola Cagnati, Rossella Gulli, et al.
The American Journal of Medicine|January 25, 2012
Current views on diagnostic approach and treatment of lymphedemaGiuseppe Murdaca, Paola Cagnati, Rossella Gulli, et al.
Clinical Immunology (Orlando, Fla.)|September 19, 2009
Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitutionGiuseppe Murdaca, Paola Contini, Maurizio Setti, et al.
Clinical and Experimental Medicine|November 15, 2015
Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapyGiuseppe Murdaca, Paola Contini, Paola Cagnati, et al.
Pageof 2